Phase 3 Meeting Scheduled With US FDA Following Positive Results Of Bone Marrow Regeneration Trial
MELBOURNE, Australia, July 12, 2010 /PRNewswire/ -- Australian regenerative medicine company, Mesoblast Limited , today announced that based on positive results from its bone marrow transplant…